The National Cancer Control Programme (NCCP) Technology Review Committee was established in March 2011 and is responsible for reviewing proposals received from industry or expert groups in Ireland for funding of new cancer drugs, or expanded indications for existing cancer drugs or related predictive laboratory tests. The recommendations are based on the degree of clinical effectiveness, the acute and chronic toxicity and the cost effectiveness of the proposed technology.
Information on the NCCP Technology Review Committee is available by clicking on the attached document.
NCCP Technology Review Committee.pdf
NCCP Technology Review Committee Terms of Reference
Details of new drugs recommended for reimbursement by the NCCP Technology Review Committee to the HSE Drug Committee are available here.
Minutes of TRC Meetings:
2018 January- December
2019 January to December
2020 January to December
2021 January to December
2022 January to December
2023 January to December
2024 January to December
2025 January to February
Meeting 1: 27th January 2025
Meeting 2: 24th February 2025
Meeting 3: 31st March 2025
Meeting 4: 1st of May 2025
Meeting 5: 26th of May
Meeting 6: 30th June 2025
Meeting 7: 28th July 2025
Meeting 8: 25th August 2025
Meeting 9: 29th September 2025
Meeting 10: 20th October 2025
Meeting 11: 24th November 2025
